FUJIFILM Biotechnologies, a CDMO for biologics, vaccines, and advanced therapies, opened its expanded site in Teesside, UK. The expansion was funded through an investment of approximately £400 million from FUJIFILM Corp. It includes the opening of a single-use biopharmaceutical CDMO facility, located at the existing FUJIFILM Biotechnologies site. 
 The UK expansion introduces 2,000 L and 5,000 L single-use bioreactors with a total capacity up to 19,000 L to provide small- ...